An enzyme-sensitive PEG hydrogel based on aggrecan catabolism for cartilage tissue engineering.
An enzyme-sensitive PEG hydrogel based on aggrecan catabolism for cartilage tissue engineering.
复制标题
DOI:
10.1002/adhm.201400277
复制
发表时间:
2015-02-18
影响因子:
10
通讯作者:
Bryant SJ
中科院分区:
文献类型:
--
作者:
Skaalure SC;Chu S;Bryant SJ
A new cartilage-specific degradable hydrogel based on photoclickable thiol-ene PEG hydrogels is presented. The hydrogel crosslinks are composed of the peptide, CRDTEGE-ARGSVIDRC, derived from the aggrecanase-cleavable site in aggrecan. This new hydrogel is evaluated for use in cartilage tissue engineering by encapsulating bovine chondrocytes from different cell sources (skeletally immature (juvenile) and mature (adult) donors and adult cells stimulated with pro-inflammatory lipopolysaccharide (LPS)) and culturing for 12 weeks. Regardless of cell source, a two-fold decrease in compressive modulus is observed by 12 weeks, but without significant hydrogel swelling indicating limited bulk degradation. For juvenile cells, a connected matrix rich in aggrecan and collagen II, but minimal collagens I and X is observed. For adult cells, less matrix, but similar quality, is deposited. Aggrecanase activity is elevated, although without accelerating bulk hydrogel degradation. LPS further decreased matrix production, but did not affect aggrecanase activity. In contrast, matrix deposition in the non-degradable hydrogels consisted of aggrecan and collagens I, II and X, indicative of hypertrophic cartilage. Lastly, no inflammatory response in chondrocytes is observed by the aggrecanase-sensitive hydrogels. Overall, we demonstrate that this new aggrecanase-sensitive hydrogel, which is degradable by chondrocytes and promotes a hyaline-like engineered cartilage, is promising for cartilage regeneration.